Mechanisms of Resistance to Alkylating Agents-Reference-Cited by-同舟云学术

Mechanisms of Resistance to Alkylating Agents

Published:1996 Issue: Volume: Page:65-81
ISSN:0927-3042
Container-title:Drug Resistance
language:
Short-container-title:

Author:

Penketh Philip G.,Shyam Krishnamurthy,Sartorelli Alan C.

Publisher

Springer US

Link

http://link.springer.com/content/pdf/10.1007/978-1-4613-1267-3_3.pdf

Reference97 articles.

1. Woolley PV, Tew KD (1988) Mechanisms of Drug Resistance in Neoplastic Cells. San Diego, CA: Academic Press, pp 1–390.

2. Waxman DJ (1990) Glutathione S-transferases: Role in alkylating agent resistance and possible target for modulation chemotherapy—a review. Cancer Res 50:6449–6454.

3. Loveless A (1969) Possible relevance of O–6 alkylation of deoxyguanosine to the mutagenicity and carcinogenicity of nitrosamines and nitrosamides. Nature 223:206–207.

4. Arrick BA, Nathan CF (1984) Glutathione metabolism as a determinant of therapeutic efficacy: A review. Cancer Res 44:4224–4232.

5. LeBlanc GA, Waxman DJ (1989) Interaction of anticancer drugs with hepatic monooxygenase enzymes. Drug Metab Rev 20:395–439.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical activity of laromustine (Onrigin™) in hematologic malignancies;Expert Review of Hematology;2009-10

2. Laromustine: The return of alkylators to non-myeloablative therapy of AML;Leukemia Research;2009-08

3. Ranpirnase (Onconase®), a cytotoxic amphibian ribonuclease, manipulates tumour physiological parameters as a selective killer and a potential enhancer for chemotherapy and radiation in cancer therapy;Expert Opinion on Biological Therapy;2008-05-14

4. Mechanisms of enhanced tumoricidal efficacy of multiple small dosages of ranpirnase, the novel cytotoxic ribonuclease, on lung cancer;Cancer Chemotherapy and Pharmacology;2007-12-05

5. Reversal of Multiple Drug Resistance in Cholangiocarcinoma by the GlutathioneS-Transferase-π-Specific InhibitorO1-Hexadecyl-γ-glutamyl-S-benzylcysteinyl-D-phenylglycine Ethylester;Journal of Pharmacology and Experimental Therapeutics;2003-06-12